tiprankstipranks
Trending News
More News >
Kaken Pharmaceutical Co Ltd (KKPCF)
OTHER OTC:KKPCF
US Market

Kaken Pharmaceutical Co (KKPCF) Ratios

Compare
4 Followers

Kaken Pharmaceutical Co Ratios

KKPCF's free cash flow for Q3 2025 was ¥0.61. For the 2025 fiscal year, KKPCF's free cash flow was decreased by ¥ and operating cash flow was ¥0.24. See a summary of the company’s cash flow.
Ratios
TTM
Mar 24Mar 23Mar 22Mar 21
Liquidity Ratios
Current Ratio
5.62 5.27 5.81 5.34 5.00
Quick Ratio
4.72 4.53 5.02 4.63 4.44
Cash Ratio
2.66 2.86 3.20 2.99 2.76
Solvency Ratio
0.39 0.27 0.45 0.58 0.75
Operating Cash Flow Ratio
0.14 0.44 0.70 0.68 1.27
Short-Term Operating Cash Flow Coverage
0.67 2.40 3.46 3.74 7.13
Net Current Asset Value
¥ 79.11B¥ 80.41B¥ 83.75B¥ 86.59B¥ 78.93B
Leverage Ratios
Debt-to-Assets Ratio
0.02 0.02 0.02 0.02 0.02
Debt-to-Equity Ratio
0.03 0.03 0.03 0.03 0.03
Debt-to-Capital Ratio
0.03 0.03 0.03 0.03 0.03
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.19 1.22 1.20 1.20 1.23
Debt Service Coverage Ratio
2.79 2.38 3.12 3.84 5.73
Interest Coverage Ratio
559.59 470.47 1.00K 1.05K 1.56K
Debt to Market Cap
0.03 0.03 0.03 0.02 0.02
Interest Debt Per Share
102.47 102.93 101.82 100.21 98.80
Net Debt to EBITDA
-3.72 -5.27 -3.49 -2.98 -1.90
Profitability Margins
Gross Profit Margin
53.49%54.20%54.68%54.56%56.57%
EBIT Margin
13.62%9.36%18.29%24.91%29.71%
EBITDA Margin
17.45%14.48%21.55%26.82%32.91%
Operating Profit Margin
13.20%10.96%22.44%23.72%29.71%
Pretax Profit Margin
13.60%9.34%18.26%24.88%29.80%
Net Profit Margin
11.14%7.45%12.56%17.88%21.71%
Continuous Operations Profit Margin
11.14%7.45%12.56%17.88%21.71%
Net Income Per EBT
81.92%79.80%68.77%71.85%72.84%
EBT Per EBIT
102.97%85.23%81.37%104.89%100.30%
Return on Assets (ROA)
4.68%3.27%5.78%8.21%12.27%
Return on Equity (ROE)
5.58%3.99%6.93%9.84%15.08%
Return on Capital Employed (ROCE)
6.23%5.50%11.68%12.52%19.46%
Return on Invested Capital (ROIC)
5.04%4.27%7.82%8.76%13.79%
Return on Tangible Assets
4.89%3.41%6.08%8.24%12.30%
Earnings Yield
6.13%3.92%6.46%8.01%9.84%
Efficiency Ratios
Receivables Turnover
3.03 3.79 3.75 3.65 4.09
Payables Turnover
4.72 5.38 5.80 3.98 4.46
Inventory Turnover
1.95 2.15 2.30 2.24 3.16
Fixed Asset Turnover
2.84 2.86 2.95 3.00 3.50
Asset Turnover
0.42 0.44 0.46 0.46 0.57
Working Capital Turnover Ratio
0.81 0.81 0.83 0.84 1.10
Cash Conversion Cycle
229.98 198.39 193.03 171.03 123.00
Days of Sales Outstanding
120.30 96.36 97.26 100.03 89.17
Days of Inventory Outstanding
187.02 169.93 158.68 162.79 115.60
Days of Payables Outstanding
77.34 67.91 62.91 91.79 81.77
Operating Cycle
307.31 266.29 255.94 262.83 204.77
Cash Flow Ratios
Operating Cash Flow Per Share
68.29 246.28 351.15 372.64 701.79
Free Cash Flow Per Share
10.86 187.56 265.39 313.40 645.53
CapEx Per Share
57.42 58.72 85.76 59.24 56.26
Free Cash Flow to Operating Cash Flow
0.16 0.76 0.76 0.84 0.92
Dividend Paid and CapEx Coverage Ratio
0.33 1.18 1.49 1.78 3.39
Capital Expenditure Coverage Ratio
1.19 4.19 4.09 6.29 12.47
Operating Cash Flow Coverage Ratio
0.67 2.40 3.46 3.74 7.13
Operating Cash Flow to Sales Ratio
0.04 0.13 0.18 0.19 0.31
Free Cash Flow Yield
0.31%5.08%6.82%7.23%12.83%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
16.30 25.52 15.47 12.48 10.16
Price-to-Sales (P/S) Ratio
1.82 1.90 1.94 2.23 2.21
Price-to-Book (P/B) Ratio
0.91 1.02 1.07 1.23 1.53
Price-to-Free Cash Flow (P/FCF) Ratio
319.11 19.70 14.66 13.83 7.79
Price-to-Operating Cash Flow Ratio
50.77 15.00 11.08 11.63 7.17
Price-to-Earnings Growth (PEG) Ratio
0.35 -0.60 -0.56 -0.42 0.92
Price-to-Fair Value
0.91 1.02 1.07 1.23 1.53
Enterprise Value Multiple
6.69 7.86 5.53 5.34 4.80
EV to EBITDA
6.69 7.86 5.53 5.34 4.80
EV to Sales
1.17 1.14 1.19 1.43 1.58
EV to Free Cash Flow
205.02 11.79 8.98 8.88 5.58
EV to Operating Cash Flow
32.62 8.98 6.79 7.47 5.13
Tangible Book Value Per Share
3.61K 3.46K 3.43K 3.51K 3.27K
Shareholders’ Equity Per Share
3.81K 3.63K 3.63K 3.53K 3.28K
Tax and Other Ratios
Effective Tax Rate
0.18 0.20 0.31 0.28 0.27
Revenue Per Share
1.91K 1.94K 2.00K 1.94K 2.28K
Net Income Per Share
212.66 144.79 251.44 347.37 494.89
Tax Burden
0.82 0.80 0.69 0.72 0.73
Interest Burden
1.00 1.00 1.00 1.00 1.00
Research & Development to Revenue
0.17 0.22 0.11 0.09 0.07
SG&A to Revenue
<0.01 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.32 1.36 0.96 0.77 1.03
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis